Close Menu

In an article in last week's Genome Biology, scientists used sys bio tools to study how some highly disordered proteins avoid degradation in order to carry out their function. Combining sequencing, gene expression, and proteomic information, they were able to see that not only do disordered proteins have a greater proportion of predicted ubiquitination sites, but also their transcripts have higher proportions of predicted miRNA target sites and higher mRNA decay rates.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.